Global

Bessemer Venture Partners is a leading venture capital firm that partners with entrepreneurs from their early days through every stage of growth. With a history rooted in the Carnegie Steel empire, Bessemer has a long tradition of investing in transformative companies across various industries. The firm is committed to supporting entrepreneurs with capital, strategic guidance, and a robust network to build enduring companies.

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

KKR is a leading global investment firm founded in 1976, known for its pioneering role in the private equity industry. The firm is committed to delivering strong returns and shared success to its clients and the world at large. KKR invests across various asset classes, including private equity, infrastructure, real estate, and credit, with a focus on fortifying companies and communities. The firm emphasizes a culture of shared ownership and long-term value creation, aligning its interests with those of its investors and portfolio companies.

Warburg Pincus LLC is a pioneer in global growth investing, operating as a private partnership since 1966. The firm focuses on helping investors and management teams achieve enduring success across market cycles. With over $86 billion in assets under management and more than 230 companies in its active portfolio, Warburg Pincus is diversified across stages, sectors, and geographies. The firm has invested in over 1,000 companies globally across private equity, real estate, and capital solutions strategies.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.

Mitsui & Co. Global Investment, Inc. is a venture capital firm with over 20 years of experience, focusing on guiding entrepreneurs onto the global stage. The firm goes beyond financial support, offering strategic guidance and leveraging its vast network to facilitate key partnerships. With a commitment to improving human welfare, Mitsui partners with exceptional teams to reinvent industries worldwide.

Gilde Healthcare is a specialized healthcare investor managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. The firm focuses on investing in businesses that enable better care at lower cost, with a strong presence in Europe and North America. Gilde Healthcare is headquartered in Utrecht, the Netherlands, with additional offices in Frankfurt, Germany, and Boston, USA.

Norwest Venture Partners is a multi-stage investment firm with a history of delivering top quartile returns over the past 60 years. The firm focuses on partnering with founder-managed or capital-efficient businesses, helping them scale from double-digit to triple-digit revenues. Norwest has navigated various economic cycles and remains committed to building strong relationships with its portfolio companies, emphasizing trust and cultural alignment.

SR One is a biotechnology venture capital firm that partners with founders and entrepreneurs to translate innovative science into medicines. With a transatlantic presence, SR One focuses on companies with strong fundamentals and novel approaches to addressing diseases, aiming to reimagine today's science for tomorrow's medicines.

Gore Range Capital is a venture capital firm focused on early-stage investments in skin health businesses. Founded in 2015, the firm leverages its team's extensive healthcare expertise to partner with industry pioneers and bring skin health innovations to market. Gore Range Capital combines the operational focus of private equity with the early-stage guidance typical of venture capital, aiming to improve dermatological treatments and technologies. The firm is committed to advancing healthcare through research, science, innovation, and operating excellence, with a specialized focus in dermatology, cancer, cardiovascular, and technology-driven medical innovation.

VTC Ventures is a venture capital firm that invests in early-stage life sciences and high-growth technology companies. It operates through two main investment vehicles: the VTC Innovation Fund, focusing on Series A and B rounds, and the VTC Seed Fund, targeting seed stage investments. Primarily funded by Virginia Tech and Carilion Clinic, VTC Ventures aims to create long-term value within the Virginia Tech and Carilion Clinic ecosystem, while also pursuing high-growth opportunities across Virginia, the Mid-Atlantic, and nationwide.

Rosetta Capital is a UK-based venture capital firm specializing in the life sciences and medical device sectors. With a global investment approach, the firm focuses on building leading healthcare companies and breakthrough technologies that enhance human lives. Rosetta Capital primarily invests through direct secondary transactions, providing flexible liquidity solutions to investors and corporations. Over its 20+ year history, the firm has made over 50 venture investments, demonstrating extensive expertise in executing complex transactions efficiently.

UTEC, founded in 2004, is a venture capital firm that collaborates with universities and research institutions globally, focusing on science and technology to create new industries that address global and human challenges. With a strong emphasis on seed and early-stage investments, UTEC has managed five funds totaling approximately 850 billion yen, investing in over 150 startups, with 20 achieving IPOs and 20 undergoing M&A. UTEC's mission is to leverage capital, talent, and knowledge to solve world and human issues through innovative startups.

Longitude Capital is a venture capital firm specializing in venture growth investments in biotechnology, medical technology, and health solutions companies. The firm focuses on improving clinical outcomes, enhancing patient quality of life, and reducing the cost of care. Since its inception in 2006, Longitude Capital has raised over $2 billion across six funds, demonstrating a strong track record in sourcing, managing, and exiting investments across various market cycles. The firm employs a balanced portfolio strategy, investing in clinical-stage and commercial-stage companies with clinically de-risked assets and favorable valuations. Longitude Capital leverages its extensive industry network and proprietary research to identify new investment opportunities and utilizes a variety of investment structures to optimize returns for stakeholders.

Bain Capital Life Sciences, founded in 2016, leverages Bain Capital's extensive history in healthcare and life sciences investing. The firm focuses on investing in biopharmaceutical, medical device, diagnostic, and life science tool companies globally, aiming to drive medical innovation and improve the lives of patients with unmet medical needs. With a team of over 25 professionals, Bain Capital Life Sciences provides strategic support to clinical and commercial-stage companies, facilitating critical phases of value creation.

Oberland Capital is a private investment firm dedicated to funding innovation in the global healthcare industry. With approximately $3.2 billion in assets under management, the firm specializes in flexible investment structures tailored to meet the specific needs of its partners. Oberland Capital offers a broad range of creative financing solutions, including the monetization of royalty streams, acquisition of future product revenues, project-based financing structures, and investments in traditional debt and equity. The firm is committed to accelerating the development and commercialization of promising healthcare products to create value for its partners and transform patient care.